Goodwin to manufacture ADC for Aspyrian
Aspyrian Therapeutics has selected CDMO Goodwin Biotechnology to complete process development, scale-up, and cGMP manufacturing of their novel antibody drug conjugate (ADC).
Archives for June 9, 2015
update
Data from all UK-funded vaccine trials to be published says PM
Results from all UK-funded vaccine trials will be made public according to Prime Minister David Cameron, who suggested failure to share data exacerbated the Ebola outbreak.
Netherlands to help India develop, mass produce measles-rubella vaccine
The Netherlands and India have signed a MOU (Memorandum of Understanding) under which a government-based institute of the Netherlands will extend technical support for the development and manufacturing of the measles-rubella vaccine.
Patient groups express safety concerns about US FDA's biosimilar guidance
A coalition of patient groups has echoed AbbVie with concerns surrounding labeling and interchangeability in the US FDA’s final biosimilar guidelines.
update
EIB loans Poland's biggest drugmaker €45m to develop biosimilars
The European Investment Bank (EIB) has loaned Polpharma €45m to fund development of biosimilars and improve access to medicines in Europe.